Abstract:Introduction: Inflammatory bowel disease (IBD) is a common clinical problem. Central neurons of the dorsal motor nucleus of the vagus (DMNV) which project to the enteric nervous system have been found to be reduced in number by intestinal inflammation. In vitro, pro-inflammatory cytokines functionally alter DMNV neurons. Ghrelin is a gastrointestinal peptide which is elevated in patients with IBD and has been implicated as an inflammatory mediator. The hypothesis of this study was that ghrelin attenuates the functional and survival effects of pro-inflammatory cytokines on DMNV neurons in vitro. Methods: DMNV neurons were isolated from neonatal rat brainstem using microdissection and enzymatic digestion. The primary cell culture was maintained for one week prior to experimentation. Apoptosis was measured by a commercially available colorimetric enzyme sandwich -linked immunosorbent assay (ELISA). Cell proliferation was measured using a commercially available colorimetric ELISA after 3 hours of BrdU incorporation. Single-cell cytoplasmic calcium transients were used as a functional assay. Intracellular calcium transients were determined from the ratio of fluorescence intensity of fura-2-AM at 340 and 380 nm. Data were analyzed using ANOVA. Results are expressed as mean ± SEM. Results: BrdU cell proliferation ELISA was performed after 24 hours incubation with ghrelin 100 nM alone, IL-1β, TNF-α, or IL-6 at 1 ng/ml alone, or cytokine 1 ng/ml co-incubated with ghrelin 100nM. Compared to control, ghrelin alone significantly increased neuronal proliferation by 36% ± 5% above control (p = 0.01). Cell proliferation was significantly decreased with cytokine alone (74% ± 5%, 58% ± 4%, 56% ± 5% vs. control, respectively; p <0.001 for each cytokine). Co-incubation of IL-6 or TNF-α with ghrelin returned cell proliferation to control levels, but the addition of ghrelin to IL-1β did not change the effect of IL-1β alone. Apoptosis was measured after 24 hours incubation with ghrelin 10 or 100 nM alone, IL-1β, TNF-α, or IL-6 either at 10 ng/ml alone, or cytokine 10 ng/ml co-incubated with ghrelin 10nM. There was no significant change in neuronal apoptosis after 24 hours exposure to ghrelin 10 or 100 nM (91% ± 6% and 103% ± 6% vs. control; p > 0.05). Apoptosis of DMNV neurons was increased after exposure to IL-1β (156% ± 21% vs. control; p < 0.05), and TNF-α (160% ± 25% vs. control; p < 0.05). Exposure to IL-6 did not significantly change neuronal apoptosis (115% ± 16% vs. control; p > 0.05). Although IL-1β or TNF-α alone increased apoptosis, co-incubation with ghrelin returned apoptosis to control levels. After 24 hours incubation with ghrelin 100 nM, IL-1β, TNF-α, or IL-6 1 ng/ml alone, or cytokine 1 ng/ml co-incubated with ghrelin 100nM, the glutamate-induced increase in intracellular calcium concentration, ΔF/F0, was examined. Ghrelin alone did not significantly change maximal ΔF/F0 (88% ± 8% vs. control; p > 0.05). IL-1β, TNF-α, or IL-6 each significantly decreased maximal F/F0 (46% ± 3%, 51% ± 3%, 62% ± 6%, respectively; p < 0.001 for each cytokine). This decreased maximal ΔF/F0 was abrogated and not significantly different from control experiments when neurons were co-incubated with cytokine and ghrelin. Conclusions: In vitro, pro-inflammatory cytokines decrease cell proliferation, increase apoptosis, and alter function in DMNV neurons. These effects are attenuated by ghrelin.

Dopamine regulates colonic glial cell‐derived neurotrophic factor secretion through cholinergic dependent and independent pathways

Dopamine Inhibits Group 2 Innate Lymphoid Cell-Driven Allergic Lung Inflammation by Dampening Mitochondrial Activity

Glial-derived neurotrophic factor regulates enteric mast cells and ameliorates dextran sulfate sodium-induced experimental colitis

Dopamine Alters Lipopolysaccharide-Induced Nitric Oxide Production in Microglial Cells via Activation of D1-Like Receptors

Su1632 - Spinal Cord Stimulation Improves Glucagon-Induced Impairment in Gastric Motility and Slow Waves Via Vagal Mechanisms in Dogs

DA-DRD5 signaling controls colitis by regulating colonic M1/M2 macrophage polarization

Enhanced Contractive Tension and Upregulated Muscarinic Receptor 2/3 in Colorectum Contribute to Constipation in 6-Hydroxydopamine-Induced Parkinson’s Disease Rats

GDNF's Role in Mitigating Intestinal Reactive Gliosis and Inflammation to Improve Constipation and Depressive Behavior in Rats with Parkinson's disease

Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation

Dopaminergic Modulation of Glomerular Circuits in the Mouse Olfactory Bulb

Alterations in Dopamine Release but Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice

GDNF acutely modulates excitability and A-type K + channels in midbrain dopaminergic neurons

Role of GDNF, GFRα1 and GFAP in a Bifidobacterium-Intervention Induced Mouse Model of Intestinal Neuronal Dysplasia

135. Ghrelin Attenuates the Effects of Inflammation on Neurons in the Dorsal Motor Nucleus of the Vagus in an Inflammatory Bowel Disease Model

Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models

Neuroprotective effects of DAAO are mediated via the ERK1/2 signaling pathway in a glaucomatous animal model

Dextran sodium sulphate-induced colitis perturbs muscarinic cholinergic control of colonic epithelial ion transport.

Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity

Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease

Endogenous GDNF Is Unable to Halt Dopaminergic Injury Triggered by Microglial Activation

Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson’s Disease Mice Model